1. Home
  2. SCLX vs CNF Comparison

SCLX vs CNF Comparison

Compare SCLX & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.30

Market Cap

48.5M

Sector

Health Care

ML Signal

HOLD

CNF

CNFinance Holdings Limited each representing twenty (20)

HOLD

Current Price

$3.14

Market Cap

53.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
CNF
Founded
2011
1999
Country
United States
China
Employees
34
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
48.5M
53.8M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
SCLX
CNF
Price
$6.30
$3.14
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
97.8K
7.6K
Earning Date
04-10-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$122.52
$252.34
Revenue Next Year
$186.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.20
$0.37
52 Week High
$34.27
$24.00

Technical Indicators

Market Signals
Indicator
SCLX
CNF
Relative Strength Index (RSI) 41.26 48.46
Support Level $6.20 $2.64
Resistance Level $7.77 $3.72
Average True Range (ATR) 0.77 0.40
MACD -0.20 0.04
Stochastic Oscillator 12.64 49.62

Price Performance

Historical Comparison
SCLX
CNF

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About CNF CNFinance Holdings Limited each representing twenty (20)

CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, the group generates all of its revenues in the PRC.

Share on Social Networks: